Hair Banking: A New Frontier in Combating Hair Loss?

Hair banking, an experimental procedure, is emerging as a potential method to combat future hair loss. The process involves collecting and cloning a patient's existing hair follicles, essentially creating a 'savings account' for strands to be used later.

Unlike traditional treatments such as medications or hair transplants, which aim to manage existing hair loss, hair banking focuses on preserving hair's future potential. The technique is likened to egg or sperm banking, where a small number of hair follicles, typically 100 to 120, are extracted from the patient. These follicles are then preserved through cryopreservation, halting the aging process of the stem cells within them. Subsequently, cells from the dermal papilla at the base of the follicle are multiplied through a process known as hair cloning.

Dr. Carlos Wesley, a hair restoration surgeon, explained that the goal is to preserve hairs with the most longevity. "It's preserving the potential that we have in the early stages of our lives to be used later on when it can be of more value," he stated.

When these cloned hairs are reintroduced to the scalp, they are intended to integrate with thinning hair follicles. This process aims to reprogram the follicle, encouraging it to remain in the growth phase for an extended period. The collection of hairs for banking is described as less invasive and shorter than hair transplant procedures. It typically takes about 20 minutes, involving shaving and numbing a small area of the scalp with lidocaine before extracting hair units down to the follicle. This extraction method is known as Follicular Unit Extraction (FUE).

However, hair banking faces several hurdles. It is not yet approved by the U.S. Food and Drug Administration (FDA). While the harvesting and storage of hair do not require approval, the cloning process remains experimental. The scientific development of using preserved follicles for future cell-based hair restoration is ongoing, meaning future treatment success is not guaranteed. Furthermore, the research facilities where the harvested follicles are cloned are currently located outside the United States, with centers in countries such as Guatemala and the UK.

There is also a possibility that the cloned hairs may not successfully integrate with the scalp. Dr. Wesley noted that while the goal was to clone 100 hairs into 10,000, this has not yet been consistently achieved, and hair integration is not always successful. Despite these challenges, some patients have reported an increase in hair density after the procedure.

Experts suggest that hair banking may be most effective for individuals in the early stages of hair loss or those with a family history of hair thinning, as it can help slow down the process. It appears to be less effective for completely bald individuals and is currently best suited for the scalp and the top of the head, rather than the hairline.

Both men and women are considered potential candidates. For women, for whom hair restoration surgery can be less effective due to the unique patterns of female hair loss, hair banking might offer a viable alternative. The estimated cost is expected to be comparable to hair transplants, potentially ranging from $5,000 to $20,000, with additional annual fees for storage. Researchers hope that continued advancements may eventually make the treatment accessible for individuals with more advanced hair loss.